Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity. - Wikidata - wikimedia - TriplyDB

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.

http://www.wikidata.org/entity/Q36648933

about

Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients' heart?Acute cardiogenic shock induced by infusional 5-Fluorouracil.Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs.Chemotherapy and cardiotoxicity Capecitabine-induced cardiotoxicity: case report and review of the literature.5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?Fluoropyrimidine-Induced Cardiotoxicity: Manifestations, Mechanisms, and Management.Rituximab-induced coronary vasospasm.Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm.Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography.5-fluorouracil and cardiotoxicity: a review.

P2860

Q34306535-CC9DBEB7-32D1-42AF-9363-12BC6D26A49D Q34495319-D66E849A-6641-44BD-831E-96138C183407 Q34571555-B23F44D0-E092-4793-AA40-8C97AE91BB5D Q37045339-C37FEC76-4DBA-45E9-9588-95DE70BF0924 Q37697516-8AD5A3D3-81B0-4208-AEFE-B6DC815B7311 Q38067509-9C47D338-947E-4876-84DC-D817CC97898D Q38817372-2D4DED2C-7782-4A5C-ABD9-DD22DCD84959 Q42278780-136EA464-1E53-4124-80FB-06190F5621E1 Q47177827-AEAC000D-93FB-4889-91AF-82FA213A47B1 Q51760757-A6806B20-E90E-4164-9924-EB1394783367 Q53075042-C099F6C5-35AB-46D6-834A-7C655244652A Q55515022-69631E70-93C8-4EEE-AC88-EEFF761486EF

P2860

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.

http://www.wikidata.org/entity/Q36648933

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.

@ast

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.

@en

type

label

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.

@ast

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.

@en

prefLabel

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.

@ast

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.

@en

P1433

Q36648933-B4D8032F-9527-496E-9F22-6503DAFF2819

P1476

Q36648933-698C535D-E875-4B7A-8F87-8A0F1011555E

P2093

Q36648933-06AF0B38-ABE1-4FDF-AA45-CEBEA5820C76

Q36648933-62CC40D6-8DDB-49E8-A0FE-0ACC539F1135

Q36648933-7350FD25-9C49-4A14-AAEE-B842A318BEEA

Q36648933-9241AB7D-B427-4704-BD58-1F98BF8BE344

Q36648933-A26B00B5-5654-49F0-A65C-4466F1D7EA51

Q36648933-D36EB0F6-B3DF-4765-B2A1-501CF98EAA85

Q36648933-FFE648BC-AEE7-44CE-9430-774EFDFD537D

P2860

Q36648933-03826703-C176-421E-82A3-C699A0E2EAB0

Q36648933-0902B38F-6178-431D-BA35-F7D1E6B41370

Q36648933-15DCBFF7-D7A2-453B-B396-91E9D1FF1124

Q36648933-307B4E45-0061-4C23-93C0-A76FCF050981

Q36648933-5267201D-6E90-48A6-997F-AA6A8C16EB3A

Q36648933-7BC83538-A1F6-404D-908D-B14E4B191EDF

Q36648933-AFE79F45-8C3F-4299-ADA2-0767A68E341E

P2888

Q36648933-DE82A166-7E56-4830-8D98-1FD3F3F65E7B

P304

Q36648933-6FBDC815-E753-45EB-BAD7-C11B35A88EA5

P31

Q36648933-8EF0E86F-B1C3-44E8-91FF-A032E32CD969

P356

Q36648933-7B471953-9CBE-44A9-AA3D-24C84986251E

P407

Q36648933-A573FCA0-3A93-41A9-B528-B8BAFD1FC7D3

P433

Q36648933-2E8F9A3F-C88F-4722-BFC8-65135DA70A78

P478

Q36648933-AF5940A4-4175-48CC-A54D-DD94E20B2FF2

P50

Q36648933-6155CCA7-C29B-4882-ABE6-D66ABD5FFC36

Q36648933-E1CE794F-9702-4774-814B-2A2F1591F1E4

P577

Q36648933-F6D75629-C8B6-4B8C-B701-B848B9A2CBC8

P5875

Q36648933-0DB9DB2D-6AD0-40C3-BB02-02E1E7AE8F45

P698

Q36648933-AC235D78-B322-4530-A31C-43CE256033B9

P932

Q36648933-316A67E3-533F-4DEA-B313-8745D72CAEAB

P356

P1433

British Journal of Cancer

P1476

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity

@en

P2093

Cannita K

http://www.w3.org/2001/XMLSchema#string

Cianci G

http://www.w3.org/2001/XMLSchema#string

Di Rocco ZC

http://www.w3.org/2001/XMLSchema#string

Ficorella C

http://www.w3.org/2001/XMLSchema#string

Lanfiuti Baldi P

http://www.w3.org/2001/XMLSchema#string

Morelli MF

http://www.w3.org/2001/XMLSchema#string

Morese R

http://www.w3.org/2001/XMLSchema#string

P2860

Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity.

Cardiotoxicity of the antiproliferative compound fluorouracil.

Thymidylate synthase: a critical target for cancer chemotherapy.

Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.

The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy.

Prophylaxis of 5-fluorouracil-induced coronary vasospasm with calcium channel blockers.

The influence of 5-fluorouracil on the endothelium in small arteries. An electron microscopic study in rabbits.

P2888

P304

1507-1509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6600967

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Giampiero Porzio

Enrico Ricevuto

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10738522

http://www.w3.org/2001/XMLSchema#string

P698

12771913

http://www.w3.org/2001/XMLSchema#string

P932

2377120

http://www.w3.org/2001/XMLSchema#string